Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
OBJECTIVES: Observational and genetic studies have shown that lipoprotein(a) [Lp(a)] levels and apolipoprotein(a) [apo(a)] isoform size are both associated with coronary heart disease (CHD) risk, but the relative independence of these risk factors remains unclear. Clarification of this uncertainty i...
Egile Nagusiak: | Hopewell, J, Seedorf, U, Farrall, M, Parish, S, Kyriakou, T, Goel, A, Hamsten, A, Collins, R, Watkins, H, Clarke, R |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2014
|
Antzeko izenburuak
-
Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
nork: Hopewell, J, et al.
Argitaratua: (2014) -
Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels
nork: Hopewell, J, et al.
Argitaratua: (2010) -
A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk
nork: Kyriakou, T, et al.
Argitaratua: (2014) -
A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
nork: Kyriakou, T, et al.
Argitaratua: (2014) -
LPA NULL MUTATION GENOTYPING AND QPCR ANALYSIS REFINE KRINGLE ISOFORM ANALYSIS OF LP(A) LEVELS
nork: Kyriakou, T, et al.
Argitaratua: (2014)